Professor, Department of Pharmacology and Physiology and Department of Family Medicine 
Georgetown University Medical Center

 

Dr. Fugh-Berman teaches courses on medicinal plants and evidence-based medicine at Georgetown University Medical Center. She directs PharmedOut, a GUMC project that advances evidence-based prescribing. Her research focuses on pharmaceutical marketing practices and the culture of medicine.

Pharmacist Inspector, Pharmaceutical Control Division 
Director, The DC Center for Rational Prescribing 
District of Columbia Department of Health

 

Dr. Onumah serves as a Pharmacist Inspector with the District of Columbia Department of Health. He also directs the DC Center for Rational Prescribing (DCRx). Dr. Onumah has practiced pharmacy in the pharmacy benefit management industry, as well as the community and long-term care setting. He has a genuine passion for evidence-based value add interventions that improve healthcare outcomes. Dr. Onumah also helped implement the District of Columbia Prescription Drug Monitoring Program.

 

Adjunct Professor, Pharmacology and Physiology and Obstetrics and Gynecology
Georgetown University School of Medicine
Clinical Professor, Obstetrics and Gynecology
George Washington University School of Medicine and Health Sciences

 

Dr. Scialli is a specialist in reproductive and developmental toxicology and in obstetrics and gynecology. He directs the Reproductive Toxicology Center, a non-profit foundation in Washington, DC, which maintains Reprotox®, an online database on the effects on reproduction of drugs, chemicals, biologicals, and physical agents. Dr. Scialli founded and was editor-in-chief of the journal Reproductive Toxicology for 17 years and is a past president of the Teratology Society. Dr. Scialli is a paid expert witness in litigation regarding pharmaceutical products.

 

Associate Professor, Department of Health Policy and Management
Director, Jacobs Institute of Women's Health 
The George Washington University Milken Institute School of Public Health

 

Dr. Wood's work at GW and public advocacy focuses on the use of scientific knowledge in public policy. She previously was Assistant Commissioner for Women's Health at the U.S. Food and Drug Administration (FDA), and directed the FDA Office of Women's Health from 2000 - 2005 when she resigned on principle over continued delay of approval of emergency contraception over the counter. Prior to the FDA, Dr. Wood was the Director of Policy and Program Development at the U.S. Department of Health and Human Services' Office on Women's Health. From 1990 - 1995, Dr. Wood worked on Capitol Hill as professional staff for the Congressional Caucus for Women's Issues. Initially as Science Advisor and later as Deputy Director to the Caucus, Dr. Wood helped develop and promote the Women's Health Equity Act.

 

 

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, The George Washington University Office of CEHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships and that all conflicts of interest be identified, resolved, and communicated to learners prior to delivery of the activity.

 

The following planners, upon submission of a disclosure form, made no disclosures of commercial relationships:

 

 

*Dr. Fugh-Berman discloses that she is a paid expert witness at the request of plaintiffs in litigation regarding pharmaceutical marketing practices. She is also a subcontractor to George Washington School of Public Health.

 

† Anthony Scialli, MD is the sole member of Scialli Consulting, a firm that provides consulting services on reproductive toxicology. He also is a non-CE consultant for GlaxoSmithKline.